Allergan (AbbVie) -- Physician Payments Report
This page provides a comprehensive analysis of Allergan (AbbVie)'s payments to physicians, as reported in the CMS Open Payments (Sunshine Act) database. DoctorPharmaData enhances this data with AI-powered analysis to help patients understand pharmaceutical company spending patterns.
Spending Summary
Allergan (AbbVie) has made $4,519,693.08 in total payments to 0 physicians across 810 recorded transactions.
- Total Physician Spending: $4,519,693.08
- Total Physicians Paid: 0
- Total Payment Transactions: 810
Recent Payment Records
The following table shows the most recent payments from Allergan (AbbVie) to physicians as recorded in the CMS Open Payments database.
| Doctor | Specialty | Amount | Type | Date |
|---|---|---|---|---|
| Donna Morgan | Gastroenterology | $1,239.20 | travel | 2026-04-08 |
| Patricia Davis | Neurology | $103.01 | meals | 2026-04-07 |
| Scott Collins | Plastic Surgery | $114.34 | meals | 2026-04-07 |
| Jessica Moore | Ophthalmology | $448.93 | general | 2026-04-05 |
| John Anderson | Plastic Surgery | $8,030.33 | speaking | 2026-04-05 |
| Emily Thompson | Plastic Surgery | $6,889.39 | consulting | 2026-04-04 |
| Michelle Scott | Neurology | $218.43 | meals | 2026-04-02 |
| Rachel Parker | Plastic Surgery | $82.58 | meals | 2026-03-30 |
| Eric Sanchez | Plastic Surgery | $4,658.05 | speaking | 2026-03-29 |
| Emily Thompson | Dermatology | $5,350.52 | research | 2026-03-28 |
| Timothy Rogers | Gastroenterology | $9,060.35 | consulting | 2026-03-27 |
| Jennifer Patel | Ophthalmology | $1,527.73 | general | 2026-03-26 |
| Kevin Hill | Gastroenterology | $7,690.22 | consulting | 2026-03-26 |
| Andrew Young | Gastroenterology | $74.32 | meals | 2026-03-25 |
| Timothy Rogers | Neurology | $1,816.08 | travel | 2026-03-23 |
Understanding Pharmaceutical Company Payment Reports
Under the Physician Payments Sunshine Act, pharmaceutical and medical device companies must report all payments and transfers of value to licensed physicians and teaching hospitals. Allergan (AbbVie) is required to disclose every payment, including consulting fees, speaking engagements, meals, travel, research funding, and ownership interests.
A high spending total does not necessarily indicate improper behavior. Large pharmaceutical companies with extensive product portfolios naturally make more payments to physicians. However, examining the patterns of spending -- which specialties are targeted, which doctors receive the most, and what types of payments predominate -- can provide valuable insights for patients.
Related Resources
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice.